Abstract

ABSTRACT OBJECTIVE: The clinical benefit and cost-effectiveness of self-monitoring of blood glucose (SMBG) in adults with type 2 diabetes not using insulin has been questioned. The objective of this study was to gain insight into healthcare professionals' recommendations, practices and beliefs with respect to SMBG in well-controlled adults (glycated hemoglobin ≤7.0%) with type 2 diabetes not using insulin. METHODS: Interviews were conducted with diabetes educators, pharmacists and family physicians in 3 district health authorities in Nova Scotia, Canada. Audiotaped interviews were transcribed and analyzed using a thematic analysis approach. RESULTS: All participants recommended SMBG for persons in this population. Recommendations varied both within and between professional groups and were noted to be highly individual. SMBG results were perceived to be valuable for both patients and healthcare professionals. Participants identified clinical practice guidelines as a trustworthy source of information about SMBG in this population. CONCLUSION: Guidelines cite a lack of substantial evidence for SMBG in this population. Customized SMBG practices are important, but so are clarity and consistency in guideline recommendations. Reducing the use of SMBG in patient populations where it is unlikely to be beneficial will allow reallocation of resources to interventions with proven benefit.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.